The result was a market composed entirely of brand-name drugs, with no competition from cheaper, generic versions. Take the market for albuterol inhalers, filled with fast-acting drugs meant to ...

Generic albuterol is available in the following forms: Liquid to inhale through a nebulizer Aerosol to inhale by mouth through a metered dose inhaler Oral tablet Oral syrup The brand versions of ...

Today, the average retail price of an albuterol inhaler is $98. Unlike CFC inhalers, which have generic versions, HFA inhalers are covered by patents. While the drug itself hasn't changed ...

Albuterol 90mcg/inh; metered-dose aerosol. <4yrs: not recommended. ≥4yrs: 2 inh every 4–6 hrs as needed; 1 inh every 4 hrs may suffice. Exercise–induced bronchospasm: 2 inh 15 minutes before ...

Meaggan Pettipiece, 48, was the head coach of the Valparaiso University softball team when she was scanning her groceries at a Walmart self-checkout machine in Indiana on March 28, according to ...

This is why GSK Plc is focusing on lowering the emissions of propellant rescue inhalers, said Laura Clow, a medicine development leader at the company. GSK’s metered-dose Ventolin inhaler ...

After winning a first-in-class nod for its two-drug inhaler Airsupra last ... Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly reduced the risk ...

Albuterol inhalers are life-saving devices used by those with asthma and Chronic Obstructive Pulmonary Disease (COPD). Globally, as many as 384 million people suffer from COPD – the third leading ...

The Biden administration has reformed Medicare, gone after bogus drug patents and ... of the most widely used inhalers in the United States, including Symbicort and Ventolin.

Pharmaceutical companies are looking to change that with lower-emitting inhalers that they plan to roll out by the end of the decade. Meta must face Massachusetts social media addiction lawsuit ...

President Joe Biden’s career-defining victories over Big Pharma — reforming Medicare to lower prices and capping inhaler costs for millions of Americans with lung disease — are facing an ...